| |
| |
|
| Insider
Information: |
Coulie Bernard |
| Relationship: |
President and CEO, Dir... |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
444,532 |
|
|
Indirect Shares
|
409,317 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
853,849 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Pliant Therapeutics, Inc. |
PLRX |
President and CEO, Dir... |
2024-01-23 |
444,532 |
2024-01-23 |
409,317 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PLRX |
Pliant Therapeutics, Inc. |
President and CEO |
• • – |
2024-01-23 |
4 |
A |
$0.00 |
$0 |
D/D |
128,150 |
444,532 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
President and CEO |
• • – |
2024-01-17 |
4 |
AS |
$17.23 |
$443,173 |
D/D |
(25,721) |
316,382 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
President and CEO |
• • – |
2023-07-17 |
4 |
AS |
$18.01 |
$1,263,338 |
D/D |
(70,150) |
342,103 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
President and CEO |
• • – |
2023-07-14 |
4 |
A |
$0.00 |
$0 |
D/D |
137,500 |
412,253 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
President and CEO |
• • – |
2023-02-03 |
4 |
AS |
$33.36 |
$504,200 |
D/D |
(15,000) |
240,112 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
President and CEO |
• • – |
2023-02-03 |
4 |
OE |
$6.22 |
$93,300 |
D/D |
15,000 |
255,112 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
President and CEO |
• • – |
2023-02-02 |
4 |
OE |
$6.22 |
$93,300 |
D/D |
15,000 |
255,112 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
President and CEO |
• • – |
2023-02-02 |
4 |
AS |
$34.13 |
$513,230 |
D/D |
(15,000) |
240,112 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
President and CEO |
• • – |
2023-02-01 |
4 |
AS |
$34.15 |
$515,767 |
D/D |
(15,000) |
240,112 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
President and CEO |
• • – |
2023-02-01 |
4 |
OE |
$6.22 |
$93,300 |
D/D |
15,000 |
255,112 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
President and CEO |
• • – |
2023-01-31 |
4 |
AS |
$34.92 |
$523,755 |
D/D |
(15,000) |
240,112 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
President and CEO |
• • – |
2023-01-31 |
4 |
OE |
$2.08 |
$49,669 |
D/D |
15,000 |
255,112 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
President and CEO |
• • – |
2023-01-30 |
4 |
AS |
$33.98 |
$512,116 |
D/D |
(15,000) |
240,112 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
President and CEO |
• • – |
2023-01-30 |
4 |
OE |
$2.08 |
$31,200 |
D/D |
15,000 |
255,112 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
President and CEO |
• • – |
2023-01-27 |
4 |
OE |
$2.08 |
$31,200 |
D/D |
15,000 |
255,112 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
President and CEO |
• • – |
2023-01-27 |
4 |
AS |
$35.42 |
$535,289 |
D/D |
(15,000) |
240,112 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
President and CEO |
• • – |
2023-01-27 |
4 |
AS |
$35.09 |
$351,255 |
I/I |
(10,000) |
409,317 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
President and CEO |
• • – |
2023-01-26 |
4 |
AS |
$35.10 |
$526,425 |
I/I |
(15,000) |
419,317 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
President and CEO |
• • – |
2023-01-26 |
4 |
AS |
$35.29 |
$529,367 |
D/D |
(15,000) |
240,112 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
President and CEO |
• • – |
2023-01-26 |
4 |
OE |
$2.08 |
$31,200 |
D/D |
15,000 |
255,112 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
President and CEO |
• • – |
2023-01-25 |
4 |
OE |
$2.08 |
$31,200 |
D/D |
15,000 |
108,812 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
President and CEO |
• • – |
2023-01-25 |
4 |
A |
$0.00 |
$0 |
D/D |
146,300 |
240,112 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
President and CEO |
• • – |
2023-01-25 |
4 |
AS |
$32.40 |
$487,517 |
D/D |
(15,000) |
93,812 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
President and CEO |
• • – |
2023-01-24 |
4 |
AS |
$30.89 |
$463,389 |
D/D |
(15,000) |
93,812 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
President and CEO |
• • – |
2023-01-24 |
4 |
OE |
$2.08 |
$31,200 |
D/D |
15,000 |
108,812 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
